Drug Profile
Research programme: antiviral therapies - Immune System Regulation
Alternative Names: ISR-49Latest Information Update: 01 Apr 2021
Price :
$50
*
At a glance
- Originator Immune System Regulation
- Class Antivirals
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical HIV infections
Most Recent Events
- 22 Feb 2021 Preclinical trials in HIV infections in Sweden (unspecified route) (Immune System Regulation pipeline, February 2021)